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The Toronto Extremity Salvage Score (TESS) is widely used for the functional assessment of patients following surgery for
musculoskeletal tumours. The aim of this study was to determine if there are gender and/or age-specific changes, unrelated to
surgery, that may influence this score and the appropriateness of the questions. The TESS for lower limb was carried out in two
diﬀerent countries to see if there was variation between them. There were no statistically significant diﬀerences between the scores
obtained between the respondents from Australia or Britain either in total or between the corresponding age groups. There were
statistically significant diﬀerences in the TESS obtained between age groups with a lower score at older age groups but there was
no diﬀerence between the sexes. Patients in the age group 70+ were more likely to record activities as “not applicable” and also
have a lower score. This study has shown that age is the major factor in determining the TESS in both an Australian and British
populations of otherwise healthy people. As there were no diﬀerences between the two populations, it supports the TESS as an
international scoring system. There may be also an argument for age-specific questions.
1. Introduction
The function of patients after treatment is an important con-
sideration in the management of tumors of the extremities.
In this context, function has been conceptualized in various
ways. Examiner-dependent clinical measures and patient-
reported outcomes are the most common. Some authors
have used clinical measures, such as range of motion and
muscle strength [1, 2] or a combination of symptoms and
mobility [3, 4]. Others have used patient-reported outcomes
such as the sickness impact profile [5] and the Toronto
Extremity Salvage Score (TESS) [6, 7]. The TESS was based
on the definitions of disability, impairment, and handicap
as documented by the World Health Organization [8]. The
TESS has been used for patients after surgery for extremity
sarcoma [7, 9–11], and has been tested for validity and
reliability (6,12) but a standard of what constitutes “normal”
has not been undertaken. The questions then arise: does age
make a diﬀerence to the score; does gender make a diﬀerence
to the score and does cultural background aﬀect the score
achieved? These questions may be relevant as sarcoma
classically aﬀects specific ages; bone sarcomas generally aﬀect
those in the first and second decades of life whereas soft
tissue sarcomas more commonly aﬀect those in the sixth and
seventh decades of life. What then constitutes a normal TESS
score?
This study was developed to answer these questions and
also to assess whether the questions asked are appropriate
across ages and genders.
2. Patients and Methods
The TESS is used routinely as an assessment tool in
both Investigators’ practices. The participants for this study
were selected from the relatives/spouses of attendees at
these practices. Inclusion and exclusion criteria were first
developed using the criteria described by Davis et al. (1996)
[6]. In brief, patients were considered eligible for inclusion













Figure 1: The TESS by gender (all patients).








































































Figure 2: The TESS by age and gender (all patients).
they had no known musculoskeletal disease or undergone
joint replacement of the lower limb, and (3) they were able
to read and write English. Patients were excluded if (1)
they refused to consent to participate, (2) they had known
cognitive impairments, or (3) they failed the above inclusion
criteria. In addition, study participants were selected such
that they were in the age groups of 30–39 years, 40–49 years,
50–59 years, 60–69 years, and 70–79 years. The TESS was
administered in a paper format in the Investigators’ clinics.
The scores were then calculated using an Excel program
(Microsoft Corp, Redmond, WA, USA). Statistical analysis
of the demographic data was done using nominal and
continuous reporting. Comparisons were then analyzed for
Internet usage against the demographic data using Student’s
t test (Prism 5 software, GraphPad Software).
There were 192 participants (100 Australian and 92
British). There were 89 men and 103 women.
The compliance rate and completion rate were recorded
in addition to ambiguous answers (i.e., when more than one
response is given for a single question). In the case of an
ambiguous answer, the answer was ranked down for scoring
to the lower of the two responses.
3. Results
The scores were compared in total and then separately by
age groups and gender between those recorded by Australian
respondents and British respondents. There were no statisti-
cally significant diﬀerences between the cumulative scores or
corresponding groups individually (Table 1). Therefore, all
subsequent analyses for age and gender were done with the
two groups combined.
3.1. Age. The main question of this study was to determine
if age made a significant diﬀerence to the scores obtained.
In both populations, age did have an impact on the scores
obtained. The TESS decreased with increasing age (Figure 2).
In women the TESS dropped steadily from age 40 years with
an unexplained rise in the 50–59 year old age group. The
age group 30–39 years had statistically better TESS than all
other age groups except women aged 50–59 years (Table 2).
In men the TESS score remained relatively constant until age
70. There were no statistically significant diﬀerences between
the male age groups except the age group of 30–39 years
compared to the age group 60–69 years (P = 0.006) and all
male groups had significantly higher TESS compared to the
70–79 year old male group (Table 2).
3.2. Gender. There was no diﬀerence in scores between
the genders, the mean TESS for all women was 91 which
compared to 92 for men (P = 0.7) (see Figure 1). There were
no gender-specific diﬀerences in the rating of the activities.
It is interesting to note that there was minimal diﬀerence in
the incidence of reporting diﬃculties with kneeling with 32
of the 153 females reporting diﬃculty with kneeling which
compared to 30 males. Interestingly, 25 of the 50 Australian
women reported diﬃculty with kneeling which compared to
7 British women and 24 Australian men reported diﬃculty
with kneeling which compared to 6 British men. Similarly,
53 females reported diﬃculty getting up from kneeling which
compared to 39 males (25 Australian women and 23 British,
25 Australian men and 14 British, resp.).
3.3. Country. There was no overall diﬀerence between the
scores in Australia and England either at any age or between
the sexes. As previously mentioned, the Australian respon-
dents reported diﬃculty with kneeling more commonly than
their British counterparts. This may be a cultural peculiarity
as the British are more accustomed to kneeling before their
royalty!
3.4. Applicability. The next question of the study was to
determine if the questions asked were applicable for age and
gender. The most common questions not felt to be relevant
were those relating to sporting activities (37 respondents
reported this as a “not applicable” question), followed by
sexual activity (28 respondents) and working their usual
number of hours (27 respondents) (Table 3). Twenty-five of
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Table 1: Mean TESS at diﬀerent age groups split by country and gender and statistical relevance.
Age groups Aus versus UK Female P Aus versus UK Male P
30–39 98.5/98.3 0.9 97.8/100.0 0.9
40–49 92.5/91.5 0.9 96.8/93.5 0.4
50–59 97.4/95.4 0.5 95.5/96.5 0.8
60–69 85.4/83.5 0.8 93.7/92.5 0.8
70–79 88.1/88.9 0.9 73.7/80.2 0.6
Table 2: The TESS at diﬀerent age groups and genders and statistical relevance (P value given).
(a)
Age groups Female 40–49 Female 50–59 Female 60–69 Female 70–79 Mean TESS
Female 30–39 0.03 0.2 0.001 0.001 98.4
Female 40–49 0.2 0.2 0.4 91.9
Female 50–59 0.01 0.02 96.5
Female 60–69 0.4 86.6
Female 70–79 88.4
(b)
Age groups Male 40–49 Male 50–59 Male 60–69 Male 70–79 Mean TESS
Male 30–39 0.06 0.2 0.006 0.0002 98.9
Male 40–49 0.8 0.4 0.003 95.4
Male 50–59 0.3 0.001 96.0
Male 60–69 0.006 93.1
Male 70–79 76.4
those that answered that sport was not applicable for them
were 60 years or older. Similarly, for sexual activity, 20 were
60 years or older and 24 out of the 27 that reporting that
working their usual number of hours was not applicable were
60 years or older.
3.5. Compliance and Completion. All respondents
approached agreed to participate, the compliance rate
was 100%. There were 19 questions not answered (by 4
respondents) out of a possible 5790 questions, completion
rate of 99.7% or, conversely, 188 questionnaires were
completed out of a possible 192, completion rate of 97.9%.
Of the scores that were completed, the lowest score was
for getting up from kneeling (mean 4.3 out of a maximum
possible of 5), heavy housework (mean 4.4), kneeling (mean
4.5), walking up hills (mean 4.5), gardening and yard work
(mean 4.5) and participating in usual sport (mean 4.5). In
those who were 60 years or older, the greatest diﬃculty was
with getting up from kneeling (mean 3.8), heavy housework
(mean 4.1), kneeling (mean 4.1) and walking up hills (mean
4.1).
4. Discussion
In the past, quality of life and assessments of function
have relied on generic questionnaires such as the Short
Form-36 ([12] or the Reintegration into Normal Living
Index [13]. More thorough functional assessments after
surgical procedures are now a mandatory requirement for
the assessment of that procedure. The TESS has become the
gold standard assessment tool for function after limb salvage
surgery. Surgeon-reported outcomes are subject to bias and
patient-reported outcomes have had variable success owing
to bias, compliance, and completion. Assessments have a
maximum score but it is not known if this maximum is
achievable. Are there any factors, other than the condition
that is being investigated, that may aﬀect achievement of
that maximum score? This study has investigated the factors
of gender and age on an otherwise healthy population to
determine if these do have an influence on achieving a
maximum score. It has demonstrated that age is the most
important factor that determines the TESS.
Our study is subject to several limitations. The first
was that the number of participants was small. There are
only 10 patients in each group in each country and so
a full cross section of the population is not represented.
The fact that the participants are related in some way
to an individual with a musculoskeletal impairment may
also influence their answers as well. It has also not taken
into account other factors that have been shown to aﬀect
functional assessment such as obesity [14]. The study group
does not reflect all cultures, and it may be argued that
Great Britain and Australia do not have major cultural
diﬀerences despite over 200 years of separation and a truly
Asian population would be a more appropriate comparison
group for cultural influences. Despite this, it has shown a
cross-section of a population and confirmed that age does
4 Sarcoma
Table 3: Applicability of the questions in the TESS by country. Most common questions listed as “not applicable” by respondents. Results
given as the total questions answered as “not applicable”/total number of respondents.
Total number UK Australia
Participating in sporting activities 37/192 14/92 23/100
Participating in sexual activities 28/192 17/92 11/100
Working my usual number of hours 27/192 15/92 12/100
Completing my usual duties at work 19/192 14/92 5/100
Driving 19/192 14/92 5/100
Getting in and out of a bath 10/192 3/92 7/100
influence the TESS but not gender. This is important because
the TESS is often used as a functional assessment tool
for patients following Musc-uloskeletal tumour resection.
To do this, it is important to have a “normal control”
to compare the functional achievement obtained following
surgery. Musculoskeletal tumours can aﬀect any age but soft
tissue sarcomas are more likely to aﬀect those in the fifth or
higher decade and bone sarcomas are most likely to aﬀect
those in the first two decades of life. This study has shown
that the functional results obtained are likely to be aﬀected
by the age of the patient, not just the procedure performed.
It also gives a standard to what can be achieved in relation to
age and gender.
Reassuringly the results were essentially identical in two
diﬀerent countries which lends support to the validity of
the TESS score as a suitable international comparison. The
two countries involved are of course quite industrialised and
both studies were carried out in large cities. The relevance
of the score to other societies may of course be very diﬀerent
althoughmost of the questions would be universally relevant.
The fact that even in the over 60s most questions were
answered is also reassuring but the decreasing proportion
of questions felt to be relevant in the over 70s is simply a
reflection of the more sheltered life this population generally
leads.
This study has confirmed the usefulness of the TESS score
across a wide age range but has shown the natural fall oﬀ in
scores with ageing. Any study presenting the results of TESS
scores that includes a proportion of patients over the age of
60 needs to be aware of this.
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